Key Points
-
Activity-based protein profiling (ABPP) facilitates the discovery of deregulated enzymes in cancer.
-
Competitive ABPP yields selective inhibitors for functional characterization of cancer enzymes.
-
ABPP can be integrated with metabolomics to map deregulated enzymatic pathways in cancer.
-
ABPP can be integrated with other proteomic methods to map proteolytic pathways in cancer.
-
ABPP probes can be used to image tumour development in living animals.
Abstract
Large-scale profiling methods have uncovered numerous gene and protein expression changes that correlate with tumorigenesis. However, determining the relevance of these expression changes and which biochemical pathways they affect has been hindered by our incomplete understanding of the proteome and its myriad functions and modes of regulation. Activity-based profiling platforms enable both the discovery of cancer-relevant enzymes and selective pharmacological probes to perturb and characterize these proteins in tumour cells. When integrated with other large-scale profiling methods, activity-based proteomics can provide insight into the metabolic and signalling pathways that support cancer pathogenesis and illuminate new strategies for disease diagnosis and treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Deberardinis, R. J., Lum, J. J., Hatzivassiliou, G. & Thompson, C. B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell. Metab. 7, 11–20 (2008).
Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033 (2009).
Warburg, O. On respiratory impairment in cancer cells. Science 124, 269–270 (1956).
Warburg, O. On the origin of cancer cells. Science 123, 309–314 (1956). A seminal paper describing how cancer cells primarily depend on glycolysis for energy, showing that cancer cells have a fundamentally altered metabolism compared with normal cells.
Christofk, H. R. et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230–233 (2008). This paper shows that the M2 isoform of pyruvate kinase is responsible for the Warburg effect.
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M. & Cantley, L. C. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452, 181–186 (2008).
Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009).
Wise, D. R. et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl Acad. Sci. USA 105, 18782–18787 (2008).
DeBerardinis, R. J. et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl Acad. Sci. USA 104, 19345–19350 (2007).
Menendez, J. A. & Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nature Rev. Cancer 7, 763–777 (2007). A comprehensive review of the roles of enhanced fatty acid synthase and de novo lipogenesis in cancer.
Nomura, D. K. et al. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140, 49–61 (2010). This paper used ABPP in combination with metabolomics to show that the lipolytic enzyme MAGL regulates pro-tumorigenic fatty acid products in cancer cells.
Mohamed, M. M. & Sloane, B. F. Cysteine cathepsins: multifunctional enzymes in cancer. Nature Rev. Cancer 6, 764–775 (2006).
Brown, P. O. & Botstein, D. Exploring the new world of the genome with DNA microarrays. Nature Genet. 21, 33–37 (1999).
Golub, T. R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531–537 (1999).
Patterson, S. D. & Aebersold, R. H. Proteomics: the first decade and beyond. Nature Genet. 33, 311–323 (2003).
Yates, J. R. Mass spectral analysis in proteomics. Annu. Rev. Biophys. Biomol. Struct. 33, 297–316 (2004).
Domon, B. & Aebersold, R. Mass spectrometry and protein analysis. Science 312, 212–217 (2006).
Cravatt, B. F., Simon, G. M. & Yates, J. R., 3rd . The biological impact of mass-spectrometry-based proteomics. Nature 450, 991–1000 (2007).
Kobe, B. & Kemp, B. E. Active site-directed protein regulation. Nature 402, 373–376 (1999).
Liu, Y., Patricelli, M. P. & Cravatt, B. F. Activity-based protein profiling: the serine hydrolases. Proc. Natl Acad. Sci. USA 96, 14694–14699 (1999). This paper describes the principles of ABPP and development of probes for the serine hydrolase superfamily.
Cravatt, B. F., Wright, A. T. & Kozarich, J. W. Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. Annu. Rev. Biochem. 77, 383–414 (2008).
Fonovic, M. & Bogyo, M. Activity based probes for proteases: applications to biomarker discovery, molecular imaging and drug screening. Curr. Pharm. Des. 13, 253–261 (2007).
Vinayavekhin, N., Homan, E. A. & Saghatelian, A. Exploring disease through metabolomics. ACS Chem. Biol. 5, 91–103 (2010).
Saghatelian, A. et al. Assignment of endogenous substrates to enzymes by global metabolite profiling. Biochemistry 43, 14332–14339 (2004).
Speers, A. E., Adam, G. C. & Cravatt, B. F. Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne [3 + 2] cycloaddition. J. Amer. Chem. Soc. 125, 4686–4687 (2003).
Speers, A. E. & Cravatt, B. F. Profiling enzyme activities in vivo using click chemistry methods. Chem. Biol. 11, 535–546 (2004).
Kidd, D., Liu, Y. & Cravatt, B. F. Profiling serine hydrolase activities in complex proteomes. Biochemistry 40, 4005–4015 (2001).
Patricelli, M. P., Giang, D. K., Stamp, L. M. & Burbaum, J. J. Direct visualization of serine hydrolase activities in complex proteome using fluorescent active site-directed probes. Proteomics 1, 1067–1071 (2001).
Greenbaum, D. et al. Chemical approaches for functionally probing the proteome. Mol. Cell. Proteomics 1, 60–68 (2002).
Kato, D. et al. Activity-based probes that target diverse cysteine protease families. Nature Chem. Biol. 1, 33–38 (2005).
Saghatelian, A., Jessani, N., Joseph, A., Humphrey, M. & Cravatt, B. F. Activity-based probes for the proteomic profiling of metalloproteases. Proc. Natl Acad. Sci. USA 101, 10000–10005 (2004).
Sieber, S. A., Niessen, S., Hoover, H. S. & Cravatt, B. F. Proteomic profiling of metalloprotease activities with cocktails of active-site probes. Nature Chem. Biol. 2, 274–281 (2006).
Chan, E. W., Chattopadhaya, S., Panicker, R. C., Huang, X. & Yao, S. Q. Developing photoactive affinity probes for proteomic profiling: hydroxamate-based probes for metalloproteases. J. Am. Chem. Soc. 126, 14435–14446 (2004).
Li, Y. M. et al. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405, 689–694 (2000).
Patricelli, M. P. et al. Functional interrogation of the kinome using nucleotide acyl phosphates. Biochemistry 46, 350–358 (2007).
Cohen, M. S., Hadjivassiliou, H. & Taunton, J. A clickable inhibitor reveals context-dependent autoactivation of p90 RSK. Nature Chem. Biol. 3, 156–160 (2007).
Liu, Y. et al. Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase. Chem. Biol. 12, 99–107 (2005).
Yee, M. C., Fas, S. C., Stohlmeyer, M. M., Wandless, T. J. & Cimprich, K. A. A cell-permeable activity-based probe for protein and lipid kinases. J. Biol. Chem. 280, 29053–29059 (2005).
Kumar, S. et al. Activity-based probes for protein tyrosine phosphatases. Proc. Natl Acad. Sci. USA 101, 7943–7948 (2004).
Salisbury, C. M. & Cravatt, B. F. Activity-based probes for proteomic profiling of histone deacetylase complexes. Proc. Natl Acad. Sci. USA 104, 1171–1176 (2007).
Salisbury, C. M. & Cravatt, B. F. Optimization of activity-based probes for proteomic profiling of histone deacetylase complexes. J. Am. Chem. Soc. 130, 2184–2194 (2008).
Hekmat, O., Kim, Y. W., Williams, S. J., He, S. & Withers, S. G. Active-site peptide “fingerprinting” of glycosidases in complex mixtures by mass spectrometry. Discovery of a novel retaining beta-1,4-glycanase in Cellulomonas fimi. J. Biol. Chem. 280, 35126–35135 (2005).
Vocadlo, D. J. & Bertozzi, C. R. A strategy for functional proteomic analysis of glycosidase activity from cell lysates. Angew. Chem. Int. Ed Engl. 43, 5338–5342 (2004).
Adam, G. C., Cravatt, B. F. & Sorensen, E. J. Profiling the specific reactivity of the proteome with non-directed activity-based probes. Chem. Biol. 8, 81–95 (2001).
Weerapana, E., Simon, G. M. & Cravatt, B. F. Disparate proteome reactivity profiles of carbon electrophiles. Nature Chem. Biol. 4, 405–407 (2008).
Simon, G. M. & Cravatt, B. F. Activity-based proteomics of enzyme superfamilies: serine hydrolases as a case study. J. Biol. Chem. 285, 11051–11055 (2010).
Puustinen, P. et al. PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma. Cancer Res. 69, 2870–7 (2009).
Andreasen, P. A., Egelund, R. & Petersen, H. H. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell. Mol. Life Sci. 57, 25–40 (2000).
Jessani, N. et al. A streamlined platform for high-content functional proteomics of primary human specimens. Nature Methods 2, 691–697 (2005).
Jessani, N., Niessen, S., Mueller, B. M. & Cravatt, B. F. Breast cancer cell lines grown in vivo: what goes in isn't always the same as what comes out. Cell Cycle 4, 253–255 (2005).
Jessani, N. et al. Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. Proc. Natl Acad. Sci. USA 101, 13756–13761 (2004).
Jessani, N., Liu, Y., Humphrey, M. & Cravatt, B. F. Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc. Natl Acad. Sci. USA 99, 10335–10340 (2002).
Chiang, K. P., Niessen, S., Saghatelian, A. & Cravatt, B. F. An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. Chem. Biol. 13, 1041–1050 (2006). This paper uses ABPP coupled with metabolomics to determine that the uncharacterized enzyme KIAA1363 regulates ether lipid metabolism in aggressive cancer cells.
Shields, D. J. et al. RBBP9: a tumor-associated serine hydrolase activity required for pancreatic neoplasia. Proc. Natl Acad. Sci. USA 107, 2189–2194 (2010).
Madsen, M. A., Deryugina, E. I., Niessen, S., Cravatt, B. F. & Quigley, J. P. Activity-based protein profiling implicates urokinase activation as a key step in human fibrosarcoma intravasation. J. Biol. Chem. 281, 15997–16005 (2006).
Greenbaum, D., Medzihradszky, K. F., Burlingame, A. & Bogyo, M. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem. Biol. 7, 569–581 (2000).
Joyce, J. A. et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5, 443–453 (2004). This paper uses ABPP to identify the cathepsin class of cysteine proteases as important contributors to cancer pathogenesis.
Rolen, U. et al. Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines. Mol. Carcinog. 45, 260–269 (2006).
Blais, D. R. et al. Activity-based proteome profiling of hepatoma cells during hepatitis C virus replication using protease substrate probes. J. Proteome Res. 9, 912–923 (2009).
Blum, G., von Degenfeld, G., Merchant, M. J., Blau, H. M. & Bogyo, M. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nature Chem. Biol. 3, 668–677 (2007). This paper describes the use of ABPP probes for near-infrared imaging of protease activities in tumours in living animals.
Lee, J. & Bogyo, M. Development of near-infrared fluorophore (NIRF)-labeled activity-based probes for in vivo imaging of legumain. ACS Chem. Biol. 5, 233–243 (2010).
Edgington, L. E. et al. Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nature Med. 15, 967–973 (2009).
Blum, G., Weimer, R. M., Edgington, L. E., Adams, W. & Bogyo, M. Comparative assessment of substrates and activity based probes as tools for non-invasive optical imaging of cysteine protease activity. PLoS One 4, e6374 (2009).
Greenbaum, D. C. et al. Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design. Chem. Biol. 9, 1085–1094 (2002).
Leung, D., Hardouin, C., Boger, D. L. & Cravatt, B. F. Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nature Biotechnol. 21, 687–691 (2003).
Li, W., Blankman, J. L. & Cravatt, B. F. A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. J. Am. Chem. Soc. 129, 9594–9595 (2007).
Wright, A. T. & Cravatt, B. F. Chemical proteomic probes for profiling cytochrome p450 activities and drug interactions in vivo. Chem. Biol. 14, 1043–1051 (2007).
Wright, A. T., Song, J. D. & Cravatt, B. F. A suite of activity-based probes for human cytochrome P450 enzymes. J. Am. Chem. Soc. 131, 10692–10700 (2009).
Long, J. Z. et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nature Chem. Biol. 5, 37–44 (2009).
Coussens, L. M., Fingleton, B. & Matrisian, L. M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387–2392 (2002).
Liu, Y., Jiang, N., Wu, J., Dai, W. & Rosenblum, J. S. Polo-like kinases inhibited by wortmannin. Labeling site and downstream effects. J. Biol. Chem. 282, 2505–2511 (2007).
Bachovchin, D. A., Brown, S. J., Rosen, H. & Cravatt, B. F. Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes. Nature Biotechnol. 27, 387–394 (2009).
Bachovchin, D. A. et al. Oxime esters as selective, covalent inhibitors of the serine hydrolase retinoblastoma-binding protein 9 (RBBP9). Bioorg Med. Chem. Lett. 20, 2254–2258 (2010).
Roos, D. S. & Choppin, P. W. Tumorigenicity of cell lines with altered lipid composition. Proc. Natl Acad. Sci. USA 81, 7622–7626 (1984).
Snyder, F. & Wood, R. Alkyl and alk-1-enyl ethers of glycerol in lipids from normal and neoplastic human tissues. Cancer Res. 29, 251–257 (1969).
Long, J. Z., Nomura, D. K. & Cravatt, B. F. Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism. Chem. Biol. 16, 744–753 (2009).
Van Schaftingen, E., Rzem, R. & Veiga-da-Cunha, M. L. -2-hydroxyglutaric aciduria, a disorder of metabolite repair. J. Inherit Metab. Dis. 32, 135–142 (2009).
Koblinski, J. E., Ahram, M. & Sloane, B. F. Unraveling the role of proteases in cancer. Clin. Chim. Acta 291, 113–135 (2000).
Janicke, F. et al. Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res. Treat 24, 195–208 (1993).
Kessenbrock, K., Plaks, V. & Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52–67 (2010).
Tandon, A. K., Clark, G. M., Chamness, G. C., Chirgwin, J. M. & McGuire, W. L. Cathepsin D and prognosis in breast cancer. N. Engl. J. Med. 322, 297–302 (1990).
Van Damme, P. et al. Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis. Nature Methods 2, 771–777 (2005).
Xu, G., Shin, S. B. & Jaffrey, S. R. Global profiling of protease cleavage sites by chemoselective labeling of protein N-termini. Proc. Natl Acad. Sci. USA 106, 19310–19315 (2009).
Mahrus, S. et al. Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 134, 866–876 (2008). This paper describes an advanced N-terminal labelling method to map the precise sites of proteolytic cleavage in complex cellular systems.
Kleifeld, O. et al. Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nature Biotechnol. 28, 281–288.
Dix, M. M., Simon, G. M. & Cravatt, B. F. Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell 134, 679–691 (2008). This paper uses an integrated gel and MS platform to map proteolytic cleavage events and their effect on protein levels and structure.
Simon, G. M., Dix, M. M. & Cravatt, B. F. Comparative assessment of large-scale proteomic studies of apoptotic proteolysis. ACS Chem. Biol. 4, 401–408 (2009).
Gygi, S. P. et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnol. 17, 994–999 (1999).
Khidekel, N., Ficarro, S. B., Peters, E. C. & Hsieh-Wilson, L. C. Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain. Proc. Natl Acad. Sci. USA 101, 13132–13137 (2004).
Martin, B. R. & Cravatt, B. F. Large-scale profiling of protein palmitoylation in mammalian cells. Nature Methods 6, 135–138 (2009).
Hang, H. C. et al. Chemical probes for the rapid detection of Fatty-acylated proteins in Mammalian cells. J. Am. Chem. Soc. 129, 2744–2745 (2007).
Ward, P. S. et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17, 225–234.
Saghatelian, A. & Cravatt, B. F. Global strategies to integrate the proteome and metabolome. Curr. Opin. Chem. Biol. 9, 62–68 (2005).
Vinayavekhin, N. & Saghatelian, A. Untargeted metabolomics. Curr. Protoc Mol. Biol. 30, 1–24 (2010).
Smith, C. A., Want, E. J., O'Maille, G., Abagyan, R. & Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78, 779–787 (2006).
Wishart, D. S. et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 37, D603–D610 (2009).
Wishart, D. S. et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 35, D521–D526 (2007).
Sana, T. R., Roark, J. C., Li, X., Waddell, K. & Fischer, S. M. Molecular formula and METLIN Personal Metabolite Database matching applied to the identification of compounds generated by LC/TOF-MS. J. Biomol. Tech. 19, 258–266 (2008).
Smith, C. A. et al. METLIN: a metabolite mass spectral database. Ther. Drug Monit. 27, 747–751 (2005).
Schmelzer, K., Fahy, E., Subramaniam, S. & Dennis, E. A. The lipid maps initiative in lipidomics. Methods Enzymol. 432, 171–183 (2007).
Acknowledgements
This work was supported by the US National Institutes of Health (CA087660 and CA132630), the American Cancer Society (D.K.N.), the California Breast Cancer Research Foundation (M.M.D.), the ARCS Foundation (M.M.D.) and the Skaggs Institute for Chemical Biology.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Glossary
- Bio-orthogonal chemical handle
-
A chemical handle that can be specifically modified with reporter tags within the confines of a biological environment.
- Click chemistry
-
Chemistry that allows for quick and reliable joining of small units; the most commonly used click-chemistry reaction is the Huisgen azide-alkyne cycloaddition using a copper catalyst.
- Intravasating
-
A process in cancer metastasis in which the cancer cells invade through the basement membrane into blood vessels.
- Ether lipid
-
A lipid in which one or more of the oxygens on a glycerol backbone is bonded to an alkyl chain by an ether linkage.
Rights and permissions
About this article
Cite this article
Nomura, D., Dix, M. & Cravatt, B. Activity-based protein profiling for biochemical pathway discovery in cancer. Nat Rev Cancer 10, 630–638 (2010). https://doi.org/10.1038/nrc2901
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc2901
This article is cited by
-
Bactericidal bissulfone B7 targets bacterial pyruvate kinase to impair bacterial biology and pathogenicity in plants
Science China Life Sciences (2024)
-
Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma
Communications Biology (2023)
-
Nucleophilic covalent ligand discovery for the cysteine redoxome
Nature Chemical Biology (2023)
-
UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
British Journal of Cancer (2022)
-
Identification of fungal lignocellulose-degrading biocatalysts secreted by Phanerochaete chrysosporium via activity-based protein profiling
Communications Biology (2022)